Xarelto, Pradaxa, and all Blood Thinners

Catania & Catania, P.A. is handling lawsuits with Xarelto, Pradaxa, and other blood thinner medications:

Both Xarelto and Pradaxa were originally marketed to replace Warfarin (Coumadin) as a better alternative. However, both these drugs have been linked to serious injuries and even death.


If you or a loved one experienced complications or injuries related to Xarelto, Pradaxa, or another blood thinner medication you may be entitled to compensation. Our team of Attorneys can help. Contact Catania & Catania, P.A. for a free case evaluation now.


Xarelto was approved by the FDA in 2011 and is one of the most recent blood thinners on the market. The blood thinner is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals.

Pradaxa was approved by the FDA in 2010 to reduce the risk of strokes and pulmonary embolism in those who suffer from non-valvular atrial fibrillation. By 2011, Pradaxa’s first year after entering the market, the drug was linked to more than 500 deaths in the U.S. and was named in 932 adverse event reports by the end of 2011.

Dangerous side effects of Xarelto & Pradaxa include:

  • Uncontrolled bleeding events
  • Gastrointestinal Hemorrhage
  • Pulmonary Embolism
  • Deep Vein Thrombosis
  • Cerebrovascular Accidents and Strokes
  • Brain Bleeding
  • Death caused by uncontrolled bleeding